“…; Edelberg, Shallenberger, & Wei, 1999;Fitten, Coleman, Siembieda, Yu, & Ganzell, 1995;Meyer & Schuna, 1989;Patterson et al, 2002;Raehl, Bond, Woods, Patry, & Sleeper, 2002;Ruscin & Semla, 1996), questionnaires (Bennett et al, 2001;de Klerk, van der Heijde, Landewe, van der Tempel, & van der Linden, 2003;Yamada, Sugiyama, Ashida, Ohwaki, & Fujii, 2001), home-based measures (Brown et al, 1998;Stewart, Pearson, Luke, & Horowitz, 1998;West et al, 1997), and pharmacy-type interventions (patient education, pharmacist-developed discharge plans; Ali, Laurin, Lariviere, Tremblay, & Cloutier, 2003;Al-Rashed, Wright, Roebuck, Sunter, & Chrystyn, 2002;Grant, Devita, Singer, & Meigs, 2003;Hoffman et al, 2003;Jensen, 2003;Lowe, Raynor, Purvis, Farrin, & Hudson, 2000;Nazareth et al, 2001;Sturgess, McElnay, Hughes, & Crealey, 2003). A majority of the measures are limited by either their use by clinic patients or with patients using a specific drug type, narrow coverage of compliance issues, little utility for use with an entire drug regimen, lack of validation testing, or testing outside the United States.…”